Document is current
Any future updates will be listed below
-
Authors
Bernárdez, Claudia
Podlipnik, Sebastian
Westgate, Gillian E.
Paus, Ralf
Zamfir, Laura
Grohmann, Daniela
Sáez Moya, Manuel https://orcid.org/0009-0006-1293-4822
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct07111312 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy and Safety of a Drinkable Nutraceutical in Premenopausal Women with Telogen Effluvium: A 6-Month, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
https://doi.org/10.1007/s13555-025-01585-x
- License Information
-
More Information
Article History
Received: 23 September 2025
Accepted: 24 October 2025
First Online: 25 November 2025
Declarations
:
: Claudia Bernárdez, Sebastian Podlipnik, Gillian E Westgate and Ralf Paus work as consultants for Olistic Research Labs S.L. Laura Zamfir, Daniela Grohmann and Manuel Sáez Moya work as employees for Olistic Research Labs S.L.
: This study was reviewed and approved (approval number 20230918-EC48.23) by the Comité de Ética de la Investigación con medicamentos (CEIm) Regional de la Comunidad de Madrid in Madrid, Spain. It followed all applicable ethical guidelines, including those set by the institutional and national research committees, the Declaration of Helsinki (1964) and its later updates, as well as Good Clinical Practice standards (ICH E6 R2, EMA/CHMP/ICH/135/1995, Directive 2001/20/CE). All human participants provided written informed consent prior to their inclusion in the study. Furthermore, they also agreed to the publication of any information that could potentially identify them, if included in the manuscript.
